Actagene Oncology's Acquisition

Actagene Oncology was acquired by Ignyta on May 21, 2013.

Actagene Oncology is a San Diego based privately held biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. In …

Articles about Actagene Oncology's Acquisition: